VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
73 hedge funds and large institutions have $179M invested in Viracta Therapeutics, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 21 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
Holders
73
Holding in Top 10
–
Calls
$236K
Puts
$2K
Top Buyers
| 1 | +$9.94M | |
| 2 | +$2.72M | |
| 3 | +$2.24M | |
| 4 |
IGIM
I.G. Investment Management
Winnipeg,
Manitoba, Canada
|
+$2.08M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$1.54M |
Top Sellers
| 1 | -$5.68M | |
| 2 | -$3.98M | |
| 3 | -$1.51M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
-$1.43M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$939K |